SHIP1 and its role for innate immune regulation - novel targets for immunotherapy.

Yeoh, Wen Jie; Krebs, Philippe (2023). SHIP1 and its role for innate immune regulation - novel targets for immunotherapy. European journal of immunology, 53(12), e2350446. Wiley-VCH 10.1002/eji.202350446

Text Br_J_Haematol_-_2023_-_Schifferli.pdf - Accepted Version Restricted to registered users only until 24 September 2024. Available under License Publisher holds Copyright. Download (5MB) | Request a copy

Phosphoinositide-3-kinase/AKT (PI3K/AKT) signaling plays key roles for the regulation of cellular activity in both health and disease. In immune cells, this PI3K/AKT pathway is critically regulated by the phosphoinositide phosphatase SHIP1, which has been reported to modulate the function of most immune subsets. In this review, we summarize our current knowledge of SHIP1 with a focus on innate immune cells, where we reflect on the most pertinent aspects described in the current literature. We also present the several small molecule agonists and antagonists of SHIP1 developed the last two decades, which have led to improved outcomes in several pre-clinical models of disease. We outline these promising findings and put them in relation with human diseases with unmet medical needs, where we discuss the most attractive targets for immune therapies based on SHIP1 modulation. This article is protected by copyright. All rights reserved.

Interest & Impact

Downloads

0 since deposited on 25 Sep 2023
0 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item